We would like to share some of the latest developments in the industry and provide an outlook of some of our key activities. If you would like to receive this update straight to your inbox, please feel free to sign up to our monthly newsletter.
Grand Opening of our J.POD Toulouse Biomanufacturing Facility
We are thrilled to share some memorable moments from the grand opening of J.POD® Toulouse, France (EU) on 20 September 2024.
Highlights included:
- Opening remarks by Christian Wojczewski, CEO of Evotec, emphasizing the pivotal role of the J.POD Toulouse facility in making life-saving biologics accessible to patients worldwide.
- A roundtable discussion chaired by Linda Zuckerman, EVP, Global Head of Just – Evotec Biologics, on “Delivering on a Vision Supporting Patient Health,” featuring Pierre-André Durand (Prefect of the Occitanie and Haute-Garonne regions), Jean-Luc Moudenc (Mayor of Toulouse), and Jalil Benabdillah (VP of the Occitanie Region).
- A fireside chat between Philip Boehme, EVP, Head of Partnering and Transformation of Just – Evotec Biologics, and Richard Saynor, CEO of Sandoz, on “Expanding Access to Biotherapeutics.”
Thank you to everyone who joined us in celebrating this milestone.
The construction of J.POD® Toulouse, France (EU) benefits from French government funding as part of the Investments for the future Programme (programme d’investissements d’avenir in French) and is also supported economically by the Occitanie Region.
Upcoming Conferences
Join us at BIO-Europe! We are co-exhibiting with Evotec at booth 59 and have a meeting room (no. 327).
Join our Evotec colleagues at PEGS Europe in Spain. They will present two poster presentations:
- MytomAb: Multi-specific cytotoxicity maximizing antibodies for cancer immunotherapy
- CD2 BiTco: Novel CD2-targeted Bispecific T cell co-stimulators for cancer immunotherapy
Upcoming Virtual Roundtable
Antibody Design to Support Global Health Initiatives
Join our live virtual round table, Antibody Design to Support Global Health Initiatives, moderated by Randal Ketchem, SVP Biotherapeutic Discovery and Molecular Design, featuring experts from the Gates Foundation and other peers to discuss:
- Strategies for developing effective therapeutics with AI and ML
- The latest advancements in antibody engineering
- Collaborative efforts to address global health issues
5 December at 11:00 EST | 5:00pm CET